Insulin Nasal Spray Could Delay Cognitive Function Decline
66 Views
Studies have shown that insulin levels are lower in the central nervous systems of Alzheimer’s patients. A new study suggests that restoring insulin levels through the use of insulin nasal spray could delay the decline of cognitive function in those with Alzheimer’s and mild cognitive impairment.
Investigators from the University of Washington School of Medicine assigned 104 participants with certain types of mild cognitive impairment or Alzheimer’s disease into three groups. Over a period of four months, one group received 20 international units of insulin nasal spray per day, one group received 40 IUs and the remaining third received a placebo.
The results showed improved cognition and cerebral glucose metabolism in the insulin-receiving participants prompting the call for further study. Ask your physician.
You may be interested
Mobile Health
13 views
Mobile Health
13 views
Care On The Road: How Telemedicine Can Reach Truck Drivers
Larry Alton - August 21, 2017Telemedicine is considered a powerful tool for individuals living in rural areas, far from adequate services or in need of…
eHealth
3 views
eHealth
3 views
Where Is The Balance? Pushing Back Against Consumer Health Tech
Larry Alton - August 18, 2017When Republican Congressman Jason Chaffetz glibly remarked that Americans struggling to afford insurance should choose between that and their smartphones,…
eHealth
365 views
eHealth
365 views
What to Look for in Patient Solutions Software
Robert Cordray - August 17, 2017The medical sector is one area where technology has had a significant impact, largely by providing tools that simplify many…
